Jeddah Health Cluster Two Signs Cooperation Agreement with Jamjoom Pharma to Enhance Health Awareness
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies in the pharmaceutical and healthcare industries. This partnership aims to enhance the level of health services provided to citizens and residents in the Kingdom of Saudi Arabia.
The agreement focuses primarily on raising health awareness among community members through specialized awareness programs. Both parties also seek to exchange expertise and knowledge to develop human and professional capabilities in the health sector, contributing to the improvement of quality of life in accordance with the goals of Saudi Vision 2030.
For its part, Jeddah Health Cluster Two emphasized that this collaboration reflects the health sector's commitment to building effective partnerships with the private sector. This initiative is expected to contribute to providing innovative solutions that support the pharmaceutical sector and ensure the provision of best health practices for patients in the Jeddah region.
This step is part of a series of efforts made by the Saudi Ministry of Health to develop health infrastructure and expand the scope of services. Jamjoom Pharma is considered an important national partner with extensive experience in supporting the health sector and developing pharmaceuticals locally.
In conclusion, this agreement strengthens the integration of roles between government institutions and national companies. Joint programs between the two parties are expected to begin in the near future, which will lead to tangible results that positively reflect on the health and safety of the community in the Kingdom.